Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats

Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome

Inflammation and the development of atherosclerosis

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats

Advances in pharmacologic modulation of nitric oxide in hypertension

Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers

Combined use of calcium channel blockers and inhibitors of the renin-angiotensin system for treating hypertension